ZNF234
gene geneOn this page
Also known as HZF4
Summary
ZNF234 (zinc finger protein 234, HGNC:13027) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 234 (Q14588). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 10780 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 87 total
- MANE Select transcript:
NM_006630
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13027 |
| Approved symbol | ZNF234 |
| Name | zinc finger protein 234 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HZF4 |
| Ensembl gene | ENSG00000263002 |
| Ensembl biotype | protein_coding |
| OMIM | 604750 |
| Entrez | 10780 |
Gene structure
Transcript identifiers
Ensembl transcripts: 28 — 26 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000426739, ENST00000590748, ENST00000590795, ENST00000592437, ENST00000896265, ENST00000896266, ENST00000896267, ENST00000896268, ENST00000896269, ENST00000896270, ENST00000896271, ENST00000896272, ENST00000896273, ENST00000896274, ENST00000896275, ENST00000896276, ENST00000896277, ENST00000896278, ENST00000896279, ENST00000896280, ENST00000929192, ENST00000929193, ENST00000929194, ENST00000971544, ENST00000971545, ENST00000971546, ENST00000971547, ENST00000971548
RefSeq mRNA: 2 — MANE Select: NM_006630
NM_001144824, NM_006630
CCDS: CCDS46101
Canonical transcript exons
ENST00000426739 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001309205 | 44156252 | 44160313 |
| ENSE00001640854 | 44142314 | 44142367 |
| ENSE00001676261 | 44144557 | 44144647 |
| ENSE00001799792 | 44141554 | 44141733 |
| ENSE00002501033 | 44148771 | 44148897 |
| ENSE00003618504 | 44150413 | 44150505 |
Expression profiles
Bgee: expression breadth ubiquitous, 183 present calls, max score 84.49.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9078 / max 86.1217, expressed in 1501 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176251 | 2.4353 | 1291 |
| 176250 | 1.4725 | 891 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.99 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.35 | gold quality |
| apex of heart | UBERON:0002098 | 79.12 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.05 | gold quality |
| cortical plate | UBERON:0005343 | 78.50 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.32 | gold quality |
| right adrenal gland | UBERON:0001233 | 78.27 | gold quality |
| left adrenal gland | UBERON:0001234 | 77.84 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.71 | gold quality |
| adrenal gland | UBERON:0002369 | 77.38 | gold quality |
| adrenal cortex | UBERON:0001235 | 76.70 | gold quality |
| ventricular zone | UBERON:0003053 | 76.61 | gold quality |
| left ovary | UBERON:0002119 | 75.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.35 | gold quality |
| right ovary | UBERON:0002118 | 75.30 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 75.27 | gold quality |
| right atrium auricular region | UBERON:0006631 | 74.96 | gold quality |
| right coronary artery | UBERON:0001625 | 74.86 | gold quality |
| lower esophagus | UBERON:0013473 | 74.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 74.75 | gold quality |
| colonic epithelium | UBERON:0000397 | 74.60 | gold quality |
| rectum | UBERON:0001052 | 74.57 | gold quality |
| ovary | UBERON:0000992 | 74.54 | gold quality |
| heart left ventricle | UBERON:0002084 | 74.52 | gold quality |
| gall bladder | UBERON:0002110 | 74.49 | gold quality |
| metanephros cortex | UBERON:0010533 | 74.49 | gold quality |
| sural nerve | UBERON:0015488 | 74.45 | gold quality |
| monocyte | CL:0000576 | 74.36 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 74.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.37 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2549.1 | ZNF234 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
83 targeting ZNF234, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 234 — Q14588 (reviewed: Q14588)
Alternative names: Zinc finger protein 269, Zinc finger protein HZF4
All UniProt accessions (2): Q14588, K7ELL2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001138296, NP_006621* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (26 total): zinc finger region 19, sequence variant 2, sequence conflict 2, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14588-F1 | 74.75 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 57 (showing top):
LIAO_METASTASIS, DODD_NASOPHARYNGEAL_CARCINOMA_UP, DANG_BOUND_BY_MYC, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, JOHNSTONE_PARVB_TARGETS_3_DN, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, H1_6_TARGET_GENES, RYBP_TARGET_GENES, ZNF8_TARGET_GENES, ZNF92_TARGET_GENES, ZSCAN2_TARGET_GENES, MIR5688, MIR548AZ_5P
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF234 | SH2D5 | Q6ZV89 | 479 |
| ZNF234 | WRAP73 | Q9P2S5 | 348 |
| ZNF234 | DOCK6 | Q96HP0 | 348 |
| ZNF234 | PROKR1 | Q8TCW9 | 311 |
| ZNF234 | A0A096LNH4 | A0A096LNH4 | 302 |
| ZNF234 | SLC6A5 | Q9Y345 | 300 |
| ZNF234 | MALRD1 | Q5VYJ5 | 297 |
| ZNF234 | SLC38A4 | Q969I6 | 296 |
| ZNF234 | TIMM29 | Q9BSF4 | 290 |
| ZNF234 | SYT15 | Q9BQS2 | 290 |
| ZNF234 | CEACAM19 | Q7Z692 | 288 |
| ZNF234 | OR2L13 | Q8N349 | 287 |
| ZNF234 | KIF26A | Q9ULI4 | 285 |
| ZNF234 | SNAPC1 | Q16533 | 284 |
| ZNF234 | ZNF618 | Q5T7W0 | 273 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CDC42 | ZNF234 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NDEL1 | ZNF234 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CLIC6 | ZNF234 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZNF234 (Biochemical Activity), ZNF234 (Affinity Capture-MS), ZNF234 (Two-hybrid), ZNF234 (Affinity Capture-MS), ZNF234 (Affinity Capture-RNA), ZNF234 (Two-hybrid), ZNF234 (Affinity Capture-RNA), ZNF234 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1209 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:44141662:GGACT:G | donor_gain | 1.0000 |
| 19:44142368:G:GG | donor_gain | 1.0000 |
| 19:44144750:C:G | donor_gain | 1.0000 |
| 19:44148769:AGGAG:A | acceptor_gain | 1.0000 |
| 19:44148770:GGA:G | acceptor_gain | 1.0000 |
| 19:44148770:GGAGG:G | acceptor_gain | 1.0000 |
| 19:44148881:G:GT | donor_gain | 1.0000 |
| 19:44148894:GTGG:G | donor_gain | 1.0000 |
| 19:44148896:GG:G | donor_gain | 1.0000 |
| 19:44148897:GG:G | donor_gain | 1.0000 |
| 19:44148898:G:GG | donor_gain | 1.0000 |
| 19:44148898:GTG:G | donor_loss | 1.0000 |
| 19:44148899:T:G | donor_loss | 1.0000 |
| 19:44148903:G:GT | donor_gain | 1.0000 |
| 19:44141583:G:T | donor_gain | 0.9900 |
| 19:44141663:G:T | donor_gain | 0.9900 |
| 19:44141663:GACT:G | donor_gain | 0.9900 |
| 19:44142366:ACGTG:A | donor_loss | 0.9900 |
| 19:44142367:CGTG:C | donor_loss | 0.9900 |
| 19:44142368:G:GA | donor_loss | 0.9900 |
| 19:44142369:T:A | donor_loss | 0.9900 |
| 19:44144553:ATAGT:A | acceptor_gain | 0.9900 |
| 19:44144554:T:G | acceptor_gain | 0.9900 |
| 19:44144555:A:AG | acceptor_gain | 0.9900 |
| 19:44144556:G:GG | acceptor_gain | 0.9900 |
| 19:44144556:GT:G | acceptor_gain | 0.9900 |
| 19:44148768:TAGG:T | acceptor_gain | 0.9900 |
| 19:44148769:A:AG | acceptor_gain | 0.9900 |
| 19:44148769:AG:A | acceptor_gain | 0.9900 |
| 19:44148769:AGGA:A | acceptor_gain | 0.9900 |
AlphaMissense
4692 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:44156989:T:C | F325L | 0.996 |
| 19:44156991:C:A | F325L | 0.996 |
| 19:44156991:C:G | F325L | 0.996 |
| 19:44157241:T:C | F409L | 0.996 |
| 19:44157243:C:A | F409L | 0.996 |
| 19:44157243:C:G | F409L | 0.996 |
| 19:44157325:T:C | F437L | 0.996 |
| 19:44157327:C:A | F437L | 0.996 |
| 19:44157327:C:G | F437L | 0.996 |
| 19:44157493:T:C | F493L | 0.996 |
| 19:44157495:T:A | F493L | 0.996 |
| 19:44157495:T:G | F493L | 0.996 |
| 19:44157745:T:C | F577L | 0.996 |
| 19:44157747:C:A | F577L | 0.996 |
| 19:44157747:C:G | F577L | 0.996 |
| 19:44156905:T:C | F297L | 0.995 |
| 19:44156907:C:A | F297L | 0.995 |
| 19:44156907:C:G | F297L | 0.995 |
| 19:44157577:T:C | F521L | 0.995 |
| 19:44157579:C:A | F521L | 0.995 |
| 19:44157579:C:G | F521L | 0.995 |
| 19:44157829:T:C | F605L | 0.995 |
| 19:44157831:C:A | F605L | 0.995 |
| 19:44157831:C:G | F605L | 0.995 |
| 19:44156821:T:C | F269L | 0.994 |
| 19:44156823:C:A | F269L | 0.994 |
| 19:44156823:C:G | F269L | 0.994 |
| 19:44157008:T:C | L331P | 0.994 |
| 19:44157157:T:C | F381L | 0.994 |
| 19:44157159:C:A | F381L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000282031 (19:44153031 C>A), RS1000418865 (19:44153283 G>A), RS1000711097 (19:44160360 A>G), RS1000738174 (19:44140507 C>T), RS1000803414 (19:44150867 C>T), RS1001252925 (19:44143088 C>T), RS1001390350 (19:44143333 G>A,T), RS1001640006 (19:44149760 C>A,T), RS1001871180 (19:44144726 C>T), RS1002087721 (19:44155012 C>T), RS1002242820 (19:44148113 T>G), RS1002641697 (19:44154251 C>T), RS1002701513 (19:44148477 G>A), RS1002843700 (19:44150992 G>A), RS1002946174 (19:44144477 G>A)
Disease associations
OMIM: gene MIM:604750 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation, affects methylation | 3 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| 2-butenal | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.